Honored to see Tevogen.AI recognized by @Microsoft at #FabCon as an ISV. AI in biotech is shifting from models to systems—continuous learning, real-world feedback, and scale. Just getting started. #AI #Biotech $TVGN $MSFT @arunulag

"What are you actually seeing from PredicTcell?" Early beta: Recall up to 92%, Precision to 48%, true positives rising. Built on 665M peptides, solving a real gap in precision immunotherapy. Preliminary results, but I'm comfortable sharing them. $TVGN #Biotech #AI

Going public was day one not the finish line. This is what AI moving from promise to platform looks like: fewer false positives, massive scale, biology-first insight - not model theater. From analyzing single proteins to predicting the proteome. $TVGN #AIinHealthcare #CIO

Great AI & Digital cohort by Millennium Alliance CIO consensus: • Boards want defensible AI ROI • Speed to market is now strategic • Shift to continuous delivery Question for leaders & investors: how are you measuring AI value at the board level? #TVGN #CIO #TevogenAI